SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:uu-222605"
 

Search: onr:"swepub:oai:DiVA.org:uu-222605" > The effect of the U...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Dias, M M (author)

The effect of the UGT1A1*28 allele on survival after irinotecan-based chemotherapy : a collaborative meta-analysis

  • Article/chapterEnglish2014

Publisher, publication year, extent ...

  • 2014-04-08
  • Springer Science and Business Media LLC,2014
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:uu-222605
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-222605URI
  • https://doi.org/10.1038/tpj.2014.16DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • To date, studies of irinotecan pharmacogenetics have mostly focused on the effect of the UGT1A1*28 allele on irinotecan-related toxicity. However, the clinical utility of routine UGT1A1*28 genotyping to pre-emptively adjust irinotecan dosage is dependent upon whether UGT1A1*28 also affects patient survival following irinotecan therapy. Previous observational studies evaluating the influence of UGT1A1*28 on survival have shown contradictory results. A systematic review and meta-analysis of both published and unpublished data were performed to summarize the available evidence of the relationship between the UGT1A1*28 allele and patient survival related to irinotecan therapy. Overall and progression-free survival meta-analysis data were available for 1524 patients and 1494 patients, respectively. The difference in the survival between patients of different UGT1A1*28 genotypes (homozygous, heterozygous or wild-type) who had received irinotecan was not found to be statistically significant. There was also no evidence of irinotecan dose, regimen or line of therapy having an impact on this association.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Pignon, J-P (author)
  • Karapetis, C S (author)
  • Boige, V (author)
  • Glimelius, BengtUppsala universitet,Enheten för onkologi(Swepub:uu)bengglim (author)
  • Kweekel, D M (author)
  • Lara, P N (author)
  • Laurent-Puig, P (author)
  • Martinez-Balibrea, E (author)
  • Páez, D (author)
  • Punt, C J A (author)
  • Redman, M W (author)
  • Toffoli, G (author)
  • Wadelius, MiaUppsala universitet,Klinisk farmakogenomik och osteoporos,Clinical pharmacogenomics(Swepub:uu)miawadel (author)
  • McKinnon, R A (author)
  • Sorich, M J (author)
  • Uppsala universitetEnheten för onkologi (creator_code:org_t)

Related titles

  • In:The Pharmacogenomics Journal: Springer Science and Business Media LLC14:5, s. 424-4311470-269X1473-1150

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view